Completed PHASE2 INTERVENTIONAL 5-arm NCT01763294

A Controlled Clinical Trial of Cathodal Transcranial Direct Current Stimulation in Patients With Refractory Epilepsy

Sponsor: El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez

Interventions Nicolet Endeavor CR: 30min Nicolet Endeavor CR: 30min for 3 days Nicolet Endeavor CR: 30min for 5 days Nicolet Endeavor CR: 60min Nicolet Endeavor CR: Placebo

Updated 5 times since 2017 Last updated: Apr 5, 2015 Started: Feb 29, 2012 Primary completion: Dec 31, 2012 Completion: Apr 30, 2015

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT01763294, this PHASE2 trial focuses on Refractory Epilepsy and remains completed. Sponsored by El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez, it has been updated 5 times since 2012, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Feb 2012

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez
Massachusetts General Hospital
Spaulding Rehabilitation Hospital
University Hospital Freiburg

Data source: El Instituto Nacional de Neurologia y Neurocirugia Manuel Velasco Suarez

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Mexico City, Mexico